American International Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-400,989
| Closed | -$29.4M | – | 1082 |
|
|
2024
Q1 | $29.4M | Sell |
400,989
-2,095
| -0.5% | -$161K | 0.11% | 102 |
|
|
2023
Q4 | $32.7M | Sell |
403,084
-9,951
| -2% | -$774K | 0.13% | 84 |
|
|
2023
Q3 | $31M | Buy |
413,035
+11,846
| +3% | +$911K | 0.2% | 74 |
|
|
2023
Q2 | $30.9M | Buy |
401,189
+5,407
| +1% | +$431K | 0.19% | 84 |
|
|
2023
Q1 | $32.8M | Sell |
395,782
-518
| -0.1% | -$42.9K | 0.22% | 72 |
|
|
2022
Q4 | $34M | Sell |
396,300
-8,842
| -2% | -$700K | 0.24% | 68 |
|
|
2022
Q3 | $25M | Sell |
405,142
-7,956
| -2% | -$502K | 0.18% | 88 |
|
|
2022
Q2 | $25.5M | Sell |
413,098
-9,619
| -2% | -$596K | 0.17% | 93 |
|
|
2022
Q1 | $25.1M | Sell |
422,717
-15,194
| -3% | -$971K | 0.14% | 115 |
|
|
2021
Q4 | $31.8M | Sell |
437,911
-1,080
| -0.2% | -$74.4K | 0.16% | 93 |
|
|
2021
Q3 | $30.7M | Sell |
438,991
-6,663
| -1% | -$468K | 0.16% | 96 |
|
|
2021
Q2 | $30.7K | Sell |
445,654
-4,967
| -1% | -$332K | 0.1% | 148 |
|
|
2021
Q1 | $29.1K | Sell |
450,621
-95,077
| -17% | -$6.13M | 0.1% | 151 |
|
|
2020
Q4 | $31.8K | Sell |
545,698
-2,174,563
| -80% | -$131M | 0.12% | 128 |
|
|
2020
Q3 | $172M | Sell |
2,720,261
-413,023
| -13% | -$28.6M | 0.82% | 30 |
|
|
2020
Q2 | $241M | Sell |
3,133,284
-488,668
| -13% | -$37.5M | 1.16% | 15 |
|
|
2020
Q1 | $271M | Sell |
3,621,952
-1,564,161
| -30% | -$108M | 1.48% | 8 |
|
|
2019
Q4 | $337M | Sell |
5,186,113
-77,916
| -1% | -$5.07M | 1.3% | 19 |
|
|
2019
Q3 | $334M | Sell |
5,264,029
-218,497
| -4% | -$14.3M | 1.35% | 22 |
|
|
2019
Q2 | $370M | Sell |
5,482,526
-351,809
| -6% | -$23.1M | 1.45% | 19 |
|
|
2019
Q1 | $379M | Sell |
5,834,335
-257,329
| -4% | -$17.1M | 1.44% | 23 |
|
|
2018
Q4 | $381M | Sell |
6,091,664
-48,018
| -0.8% | -$3.36M | 1.57% | 17 |
|
|
2018
Q3 | $474M | Sell |
6,139,682
-182,990
| -3% | -$13.8M | 1.57% | 20 |
|
|
2018
Q2 | $448M | Sell |
6,322,672
-243,855
| -4% | -$17.2M | 1.56% | 21 |
|
|
2018
Q1 | $495M | Sell |
6,566,527
-19,577
| -0.3% | -$1.56M | 1.73% | 21 |
|
|
2017
Q4 | $472M | Buy |
6,586,104
+165,830
| +3% | +$12.6M | 1.55% | 30 |
|
|
2017
Q3 | $520M | Sell |
6,420,274
-29,932
| -0.5% | -$2.29M | 1.84% | 18 |
|
|
2017
Q2 | $457M | Buy |
6,450,206
+5,781
| +0.1% | +$385K | 1.63% | 23 |
|
|
2017
Q1 | $438M | Buy |
6,444,425
+77,289
| +1% | +$5.43M | 1.6% | 25 |
|
|
2016
Q4 | $456M | Buy |
6,367,136
+5,782,500
| +989% | +$430M | 1.76% | 22 |
|
|
2016
Q3 | $46.3M | Sell |
584,636
-6,903
| -1% | -$561K | 0.18% | 59 |
|
|
2016
Q2 | $49.3M | Sell |
591,539
-138,360
| -19% | -$12.3M | 0.21% | 55 |
|
|
2016
Q1 | $67M | Sell |
729,899
-40,642
| -5% | -$3.67M | 0.26% | 51 |
|
|
2015
Q4 | $78M | Buy |
770,541
+5,053
| +0.7% | +$526K | 0.32% | 47 |
|
|
2015
Q3 | $75.2M | Buy |
765,488
+11,852
| +2% | +$1.32M | 0.33% | 46 |
|
|
2015
Q2 | $88.2M | Sell |
753,636
-6,876
| -0.9% | -$751K | 0.35% | 43 |
|
|
2015
Q1 | $74.6M | Buy |
760,512
+33,822
| +5% | +$3.43M | 0.31% | 43 |
|
|
2014
Q4 | $68.5M | Sell |
726,690
-17,291
| -2% | -$1.79M | 0.3% | 43 |
|
|
2014
Q3 | $79.2M | Buy |
743,981
+11,152
| +2% | +$1.09M | 0.35% | 41 |
|
|
2014
Q2 | $60.8M | Buy |
732,829
+33,966
| +5% | +$2.64M | 0.27% | 45 |
|
|
2014
Q1 | $49.5M | Buy |
698,863
+21,814
| +3% | +$1.71M | 0.23% | 49 |
|
|
2013
Q4 | $50.9M | Sell |
677,049
-142,486
| -17% | -$9.92M | 0.25% | 50 |
|
|
2013
Q3 | $51.5M | Sell |
819,535
-137,242
| -14% | -$8.2M | 0.28% | 50 |
|
|
2013
Q2 | $49M | Buy |
+956,777
| New | +$49.9M | 0.29% | 54 |
|
Other funds holding GILD
American International Group's GILD Position: Q2 2024 in Review
American International Group sold out of Gilead Sciences (GILD) in Q2 2024, closing a stake of 400,989 shares — an estimated $29.4M sold.
American International Group first reported a position in GILD in Q2 2013 and held it in 44 quarters. The position peaked at $520M in Q3 2017. 1,678 funds tracked by Wall St. Rank hold GILD as of Q2 2024.
- American International Group reported no remaining Gilead Sciences position as of Q2 2024 after selling out during the quarter.
- American International Group sold 400,989 Gilead Sciences shares in Q2 2024, an estimated $29.4M.
- American International Group first reported a position in Gilead Sciences in Q2 2013 and held it in 44 quarters.
- American International Group's Gilead Sciences position peaked at $520M in Q3 2017.
- 1,678 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.
Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.